FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
2026 · 2nd Quarter (Apr 1 - June 30)
ADIAL PHARMACEUTICALS, INC.
Filed by RK STRATEGIES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Jul 18, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- RK STRATEGIES, INC.
- Filing UUID
- 0d7b3428-c2ad-41ca-9157-63aabf5a70ef
- Termination date
- Jun 30, 2026
Literal source text
Lobbying issues and bill citations
FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.